Member Info for Matador78

Talking about deals, I ask Jim what he considers to be his best investments so far in this area. “Greg and I were the early investors in a company called Medivation. It was worth about US$100 million when he brought investors in, including myself, and we sold it for US$14.5 billion. The Biohaven investment, the most recent one, four years ago, was probably the most successful in terms of return. We owned 54% for US$3 million and it’s worth US$3 billion now on the New York Stock Exchange.”

2 March 2020, London - EMMAC Life Sciences Group, Europe's leading independent cannabis company welcomes the decision made earlier today by the UK Government to change import restrictions on medicinal cannabis products, which will provide faster access to cannabis-based products for medicinal use resulting in UK patients not have their treatment delayed or interrupted.

EMMAC's vertically integrated supply chain and distribution network across Europe ensures that high quality medical cannabis products meet growing patient demand. EMMAC believes that Rokshaw Laboratories, its wholly owned UK manufacturer of specials with licenses to import, manufacture and securely deliver medical cannabis products ('CBPMs') direct to UK-based patients through its onsite distance pharmacy, is well placed to provide patients with "quick and uninterrupted access to cannabis-medicinal products" identified as important considerations in today's announcement by the UK Government. (https://www.gov.uk/government/news/faster-access-to-cannabis-based-medicines-as-import-restrictions-are-changed)

Antonio Costanzo, CEO of EMMAC, commented: "This is a significant milestone for the cannabis sector in the UK as well as for EMMAC, as Europe's leading medical cannabis company. Following today's announcement, patients in the UK will have quicker and more reliable access to medical cannabis. We believe this will have a significant impact on the sector by reducing costs and leading to further clinical research. EMMAC is leading the way in providing patients with the highest quality medical cannabis and we welcome the UK Government's decision made today."

Not sure people will have zoned out.

Im not inflating it. I do thi that emmac jas a special relationship with the right people in its industry. Hats what sets it apart. My only complaint is we dont own more

Ah ok I see what youre getting at.

I worked delivering prescriptions in a remote pharmacy when I was a teenager. Mostly ventolin and beccotyde.

I'm fairly sure he said we're the only known European company to export cannabis to Israel. Not the only known company to provide prescriptions in the UK

Its not company news anyway.

https://www.bbc.co.uk/news/health-51712257

Best Keep hold of them from now on

https://www.businesswire.com/news/home/20200228005122/en/AgeX-Therapeutics-Researchers-Publish-Paper-Age-Reprogramming

trade data not been showing on HL all day so its likely a tech glitch.

Thomas Nicolette terminated a director of DC Medical :' (

Who are they?

Give me a name and I'll dig the dirt.

Doggo we know who's selling mate, and it's people far too close to home. The reverse psychology advice isn't needed here.

People are selling off NCYT so no doubt thatll come back in here shortly

I continue to buy safe in the knowledge it being messed around with because its worth something

There was a lot of inconsistencies yesterday between percentages shown on LSE and H & L on quite a few stocks

48

The 500 was mine the 10k was a friend.

: )

right on cue

What if a more stable person came along and took out all the cheap shares and undercut the crafty bunch.

That would be welcome.

Easily to understand article for the O'Donnells

https://www.healtheuropa.eu/the-uks-first-operational-distance-medical-cannabis-pharmacy-launches/98039/

"We continue to commit in delivering nothing less than excellence in the virtual sports betting and casino content. Stay tuned, your immersive and innovative UX offered by our games is just about to take you to the next level."

I don't believe we'll be kept waiting long for Leap News